Calories, portions, types of food all contribute to being overweight and obese
Key Findings: Most common: Nausea (43%), diarrhea (33%), vomiting (21%) Unique to retatrutide: Dysesthesia (20.9% @ 12mg in TRIUMPH-4, 8.8% @ 9mg) Discontinuation rate: 18.2% in TRIUMPH-4, 11.3% in TRIUMPH-1 (general obesity population) compared to semaglutide 6.9%, tirzepatide 6.2% Good news: Most side effects peak during dose escalation and improve significantly after week 16 Management: Slow titration, dietary modifications, and proper timing dramatically reduce severity Understanding the Three Categories of Side Effects 1
[PubMed] Kitabchi A, Umpierrez G, Miles J, Fisher J
The BNF advises that patients presenting with neurological symptoms should receive 1000 mcg i.m
7 Dietary modifications play a crucial role in managing these discomforts